Matt Dixon, Pharm D, PhD
About Matt Dixon, Pharm D, PhD
Matt Dixon, Pharm D, PhD, is the Associate Director of Worldwide Health Economics and Outcomes Research at Bristol Myers Squibb, focusing on colorectal cancer initiatives.
Title
Matt Dixon holds the position of Associate Director, Worldwide Health Economics and Outcomes Research at Bristol Myers Squibb. He assumed this role in August 2020.
Company
Matt Dixon is currently employed at Bristol Myers Squibb. He contributes to the company by leading the Worldwide Health Economics and Outcomes Research (WWHEOR) initiatives, specifically focusing on colorectal cancer.
Education and Expertise
Matt Dixon earned a Doctor of Philosophy (Ph.D.) degree from the University of North Carolina at Chapel Hill, which he attended from 2015 to 2020. Prior to that, he completed a Doctor of Pharmacy (Pharm.D.) degree at The Ohio State University between 2011 and 2015. Additionally, he holds a Bachelor of Science (B.S.) degree from The Ohio State University, achieved from 2007 to 2011. His dual doctorate in Pharmacy (PharmD) and Philosophy (PhD) underpins his extensive expertise in health economics and outcomes research.
Previous Experience
Before his current role, Matt Dixon worked as a Worldwide Health Economics and Outcomes Research Predoctoral Fellow at Bristol Myers Squibb. His fellowship, from 2019 to 2020 for 11 months in Princeton, New Jersey, provided him with in-depth exposure to the field and the organizational culture.
Professional Responsibilities
In his role at Bristol Myers Squibb, Matt Dixon is responsible for product design and delivery within the Worldwide Health Economics and Outcomes Research (WWHEOR) team. His primary focus is on leading WWHEOR initiatives specifically targeted at colorectal cancer, leveraging his expertise to drive impactful outcomes.